![Michael Egholm](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Egholm
Chief Executive Officer at
STANDARD BIOTOOLS INC.
Net worth: 5 M $ as of 2026-06-29
Profile
Michael Egholm was the founder of Danaher Corp., founded in 2017, where the title held was Chief Technology Officer-Danaher Life Sciences from 2017 to 2021.
Current jobs include President, Chief Executive Officer & Director at Standard BioTools, Inc. since 2021; Director at Abbratech, Inc.; and Member at the Royal Danish Academy of Sciences & Letters.
Former jobs include President, CEO, Secretary, Treasurer & Director at SomaLogic, Inc.; Independent Director at IsoPlexis Corp.
from 2018 to 2022; President-Biopharmaceuticals at Pall Corp.
from 2014 to 2017; Vice President-Research at Molecular Staging, Inc.; Chief Technology Officer at Roche Applied Science from 2008 to 2010; and Chief Technology Officer at 454 Life Sciences Corp.
from 2004 to 2010.
Education includes a doctorate from the University of Copenhagen.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-08-02 | 6,235,331 ( 1.6% ) | 5 M $ | 2026-06-29 |
Michael Egholm active positions
| Companies | Position | Start |
|---|---|---|
| STANDARD BIOTOOLS INC. | Chief Executive Officer | 2021-09-30 |
Abbratech, Inc.
 Abbratech, Inc. BiotechnologyHealth Technology Develops antibodies | Director/Board Member | - |
Royal Danish Academy of Sciences & Letters | Corporate Officer/Principal | - |
Former positions of Michael Egholm
| Companies | Position | End |
|---|---|---|
| ISOPLEXIS CORPORATION | Director/Board Member | 2022-08-21 |
| DANAHER CORPORATION | Founder | 2021-08-31 |
| PALL CORPORATION | Chief Tech/Sci/R&D Officer | 2014-09-09 |
454 Life Sciences Corp.
 454 Life Sciences Corp. Medical/Nursing ServicesHealth Services Provides medical testing services to determine the nucleotide sequence of whole genomes | Chief Tech/Sci/R&D Officer | 2010-05-31 |
Roche Applied Science
 Roche Applied Science Miscellaneous Commercial ServicesCommercial Services Engages in researching molecular diagnostics | Chief Tech/Sci/R&D Officer | 2009-12-31 |
Training of Michael Egholm
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
63
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Danaher Corp.
 Danaher Corp. Medical SpecialtiesHealth Technology Provides life sciences and diagnostic services | Health Technology |
Pall Corp.
 Pall Corp. Industrial MachineryProducer Manufacturing Designs, manufactures and markets filtration & separation equipment | Producer Manufacturing |
Standard BioTools, Inc.
 Standard BioTools, Inc. Medical SpecialtiesHealth Technology Manufactures and markets innovative technologies and tools for life sciences research | Health Technology |
IsoPlexis Corp.
 IsoPlexis Corp. Medical SpecialtiesHealth Technology Develops single cell multiplexing immunoassay systems | Health Technology |
Molecular Staging, Inc.
 Molecular Staging, Inc. Medical SpecialtiesHealth Technology Develops products for the detection & measurement of proteins and nucleic acids | Health Technology |
454 Life Sciences Corp.
454 Life Sciences Corp. Medical/Nursing ServicesHealth Services Provides medical testing services to determine the nucleotide sequence of whole genomes | Health Services |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Applied Science
Roche Applied Science Miscellaneous Commercial ServicesCommercial Services Engages in researching molecular diagnostics | Commercial Services |
Royal Danish Academy of Sciences & Letters | |
SomaLogic, Inc.
 SomaLogic, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a protein biomarker discovery and clinical diagnostics company | Commercial Services |
Abbratech, Inc.
Abbratech, Inc. BiotechnologyHealth Technology Develops antibodies | Health Technology |
- Stock Market
- Insiders
- Michael Egholm
